| Dr Amy Tortorich, DO | |
|
214 E 23rd St, Cheyenne, WY 82001-3748 | |
| (215) 317-7887 | |
| Not Available |
| Full Name | Dr Amy Tortorich |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 19 Years |
| Location | 214 E 23rd St, Cheyenne, Wyoming |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568654911 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 1341 (Wyoming) | Primary |
| 207P00000X | Emergency Medicine | OSO13786 (Pennsylvania) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cheyenne Regional Medical Center | Cheyenne, WY | Hospital |
| Entity Name | Amy P Tortorich Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649519554 PECOS PAC ID: 4688829005 Enrollment ID: O20130308000268 |
News Archive
Jersey Shore University Medical Center, part of the Meridian Health family, is preparing to break ground this fall on the HOPE Tower Project - a $265 million dollar building development on the hospital's east campus that will provide a new healing outpatient experience for the community. HOPE Tower's expected date of completion is early 2018.
Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that salicylates, a class of non-steroidal inflammatory drugs (NSAIDs), reduced the proliferation and viability of cultured vestibular schwannoma cells that cause a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.
The drug, ladostigil, is a molecule that combines components from the existing drugs Azilect and Exelon. Teva's Azilect, for the treatment of Parkinson's disease, was developed by Prof. Emeritus Moussa Youdim of the Technion-Israel Institute of Technology. Azilect is the only anti-Parkinson's drug that has proven to have a disease-modifying effect. Novartis's Exelon was developed by Prof. Marta Weinstock-Rosin of Hebrew University to treat Alzheimer's disease.
According to a new study drinking four or more cups of coffee a day may reduce risk of developing endometrial cancer or womb cancer by almost 25 per cent.
› Verified 5 days ago
| Entity Name | Summit Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457802993 PECOS PAC ID: 5092094532 Enrollment ID: O20161128000947 |
News Archive
Jersey Shore University Medical Center, part of the Meridian Health family, is preparing to break ground this fall on the HOPE Tower Project - a $265 million dollar building development on the hospital's east campus that will provide a new healing outpatient experience for the community. HOPE Tower's expected date of completion is early 2018.
Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that salicylates, a class of non-steroidal inflammatory drugs (NSAIDs), reduced the proliferation and viability of cultured vestibular schwannoma cells that cause a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.
The drug, ladostigil, is a molecule that combines components from the existing drugs Azilect and Exelon. Teva's Azilect, for the treatment of Parkinson's disease, was developed by Prof. Emeritus Moussa Youdim of the Technion-Israel Institute of Technology. Azilect is the only anti-Parkinson's drug that has proven to have a disease-modifying effect. Novartis's Exelon was developed by Prof. Marta Weinstock-Rosin of Hebrew University to treat Alzheimer's disease.
According to a new study drinking four or more cups of coffee a day may reduce risk of developing endometrial cancer or womb cancer by almost 25 per cent.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy Tortorich, DO Po Box 4217, Cheyenne, WY 82003-4217 Ph: (307) 459-2626 | Dr Amy Tortorich, DO 214 E 23rd St, Cheyenne, WY 82001-3748 Ph: (215) 317-7887 |
News Archive
Jersey Shore University Medical Center, part of the Meridian Health family, is preparing to break ground this fall on the HOPE Tower Project - a $265 million dollar building development on the hospital's east campus that will provide a new healing outpatient experience for the community. HOPE Tower's expected date of completion is early 2018.
Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that salicylates, a class of non-steroidal inflammatory drugs (NSAIDs), reduced the proliferation and viability of cultured vestibular schwannoma cells that cause a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.
The drug, ladostigil, is a molecule that combines components from the existing drugs Azilect and Exelon. Teva's Azilect, for the treatment of Parkinson's disease, was developed by Prof. Emeritus Moussa Youdim of the Technion-Israel Institute of Technology. Azilect is the only anti-Parkinson's drug that has proven to have a disease-modifying effect. Novartis's Exelon was developed by Prof. Marta Weinstock-Rosin of Hebrew University to treat Alzheimer's disease.
According to a new study drinking four or more cups of coffee a day may reduce risk of developing endometrial cancer or womb cancer by almost 25 per cent.
› Verified 5 days ago
Bryan K Beck, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 214 E 23rd St, Cheyenne, WY 82001 Phone: 307-634-2273 Fax: 307-633-7671 | |
Dr. Kathern L Auer, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 214 E 23rd St, Cheyenne, WY 82001 Phone: 307-634-2273 Fax: 307-633-7671 | |
Erik Holt, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 214 E 23rd St, Upmc Shadyside Hospital, Cheyenne, WY 82001 Phone: 307-634-2273 | |
Dr. Rebecca Kay Carney Calisch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 214 E 23rd St, Cheyenne, WY 82001 Phone: 307-634-2273 | |
Daniel E Surdam, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 214 E 23rd St, Cheyenne, WY 82001 Phone: 307-634-2273 Fax: 307-633-7671 | |
Dr. Jessica Florence Jane Hughes, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 214 E 23rd St, Dept. Of Emergency Medicine, Cheyenne, WY 82001 Phone: 307-633-7670 Fax: 307-633-7469 | |
Eldon M Handrich, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 214 E 23rd St, Cheyenne, WY 82001 Phone: 307-634-2273 Fax: 307-633-7671 |